Combination chemotherapy regimen with proton pump inhibitor

This page covers all Combination chemotherapy regimen with proton pump inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H+/K+-ATPase (lansoprazole component); multiple targets (CHOP chemotherapy).

Targets

H+/K+-ATPase (lansoprazole component); multiple targets (CHOP chemotherapy)

Phase 3 pipeline (1)

• CHOP Plus Lanzoprazole · Sherief Abd-Elsalam · Oncology; Gastroenterology
  CHOP Plus Lansoprazole combines chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) with a proton pump inhibitor to treat Helicobacter pylori infection and gastric conditions.

Patent intelligence

• combination chemotherapy regimen with proton pump inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates